Jasper Clube
Gründer bei SNIPR Biome ApS
Profil
Jasper Clube is the founder of SNIPR Biome ApS, founded in 2017, where he holds the title of Chief Intellectual Property Officer.
He is also the founder of Folium Food Science Ltd., founded in 2016, where he holds the title of Director.
Currently, Mr. Clube is the Chief Patent Counsel & SVP-Intellectual Property at Kymab Ltd.
In the past, he worked as the Vice President-Intellectual Property at Domantis Ltd.
from 2001 to 2007.
He also held positions as Patent Counsel at AstraZeneca.
AS and Senior Patent Counsel at GlaxoSmithKline Pharmaceuticals SA (Belgium).
Mr. Clube completed his undergraduate degree at the University of Durham.
Aktive Positionen von Jasper Clube
| Unternehmen | Position | Beginn |
|---|---|---|
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Folium Food Science Ltd.
 Folium Food Science Ltd. Miscellaneous Commercial ServicesCommercial Services Folium Food Science Ltd. engages in research and development on biotechnology. The company was founded by Jasper Clube, Edward Blackall Fuchs, and Christian Groendahl on November 16, 2016 and is headquartered in Cambridge, the United Kingdom. | Gründer | 16.11.2016 |
SNIPR Biome ApS
 SNIPR Biome ApS Pharmaceuticals: MajorHealth Technology SNIPR Biome ApS develops bacterial composition to provide treatment for diabetes to cancer. The company was founded by Christian Grøndal and is headquartered in Kongens Lyngby, Denmark. | Gründer | 11.08.2017 |
Ehemalige bekannte Positionen von Jasper Clube
| Unternehmen | Position | Ende |
|---|---|---|
Domantis Ltd.
 Domantis Ltd. Pharmaceuticals: MajorHealth Technology Domantis Ltd. develops domain antibody therapeutics for treating highly unmet diseases. It enables DABS to serve as building blocks for therapeutics simultaneously directed at more than one disease target. The company was founded in December 2000 and is headquartered Middlesex, the United Kingdom. | Corporate Officer/Principal | - |
| AstraZeneca AS | Corporate Officer/Principal | - |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Corporate Officer/Principal | - |
Ausbildung von Jasper Clube
| University of Durham | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Domantis Ltd.
Domantis Ltd. Pharmaceuticals: MajorHealth Technology Domantis Ltd. develops domain antibody therapeutics for treating highly unmet diseases. It enables DABS to serve as building blocks for therapeutics simultaneously directed at more than one disease target. The company was founded in December 2000 and is headquartered Middlesex, the United Kingdom. | Health Technology |
| AstraZeneca AS | |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Health Technology |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
SNIPR Biome ApS
SNIPR Biome ApS Pharmaceuticals: MajorHealth Technology SNIPR Biome ApS develops bacterial composition to provide treatment for diabetes to cancer. The company was founded by Christian Grøndal and is headquartered in Kongens Lyngby, Denmark. | Health Technology |
Folium Food Science Ltd.
Folium Food Science Ltd. Miscellaneous Commercial ServicesCommercial Services Folium Food Science Ltd. engages in research and development on biotechnology. The company was founded by Jasper Clube, Edward Blackall Fuchs, and Christian Groendahl on November 16, 2016 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
